FDA 483 - OMT, LLC - September 02, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of GMT, LLC, a medical device specification developer in Fort Lauderdale, FL, revealed three significant repeat deficiencies. The firm failed to adequately establish procedures for design validation, specifically regarding aging studies for OMT Spetzler Neuro Patties, and had not properly implemented its quality audit procedure. Additionally, the inspection found that procedures for ensuring purchased products and services conform to requirements were not adequately established, leading to issues with supplier complaint handling.
ID · 11a94863-36ec-4e71-bd0b-b5d2c6187a58